MedTrace Logo

Effect of a Plant-based Ingredient on Glucose Response

NCT02218528 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2015-02-18

No results posted yet for this study

Summary

The study is designed to determine the extent to which a plant-based ingredient is able to modulate blood glucose response when administered with a meal.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Plant-based ingredient

DIETARY_SUPPLEMENT

No Plant-based ingredient

Sponsors & Collaborators

  • Unilever R&D

    lead INDUSTRY

Principal Investigators

  • Dr. Ketul Modi, MBBS · Lambda Therapeutics Research Ltd (LTRL)

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02218528 on ClinicalTrials.gov